郑绍周基于伏毒论治多发性硬化经验

王丹; 贺从从; 武继涛; 赵铎

doi:10.16368/j.issn.1674-8999.2022.05.186

意见反馈

您当前的位置：

首页 >

文章列表页 >

郑绍周基于伏毒论治多发性硬化经验

中国中医药临床案例成果库

上一篇: 基于“痿-宗气理论”辨治脊髓梗死

下一篇: 无

郑绍周基于伏毒论治多发性硬化经验
Zheng Shaozhou's Experience in Treating Multiple Sclerosis Based on Fu Du Theory
1.河南中医药大学第一附属医院，河南　郑州　450000
2.永城市人民医院，河南　永城　476610
DOI：10.16368/j.issn.1674-8999.2022.05.186

扫描看全文

王丹, 贺从从, 武继涛, 等. 郑绍周基于伏毒论治多发性硬化经验[DB/OL].（2023-09-15）[2023-11-05].http://cccl-tcm.cacm.org.cn/thesisDetails#10.16368/j.issn.1674-8999.2022.05.186

WANG Dan, HE Congcong, WU Jitao, et al. Zheng Shaozhou's Experience in Treating Multiple Sclerosis Based on Fu Du Theory[DB/OL].（2023-09-15）[2023-11-05].http://cccl-tcm.cacm.org.cn/thesisDetails#10.16368/j.issn.1674-8999.2022.05.186
王丹, 贺从从, 武继涛, 等. 郑绍周基于伏毒论治多发性硬化经验[DB/OL].（2023-09-15）[2023-11-05].http://cccl-tcm.cacm.org.cn/thesisDetails#10.16368/j.issn.1674-8999.2022.05.186 DOI：

WANG Dan, HE Congcong, WU Jitao, et al. Zheng Shaozhou's Experience in Treating Multiple Sclerosis Based on Fu Du Theory[DB/OL].（2023-09-15）[2023-11-05].http://cccl-tcm.cacm.org.cn/thesisDetails#10.16368/j.issn.1674-8999.2022.05.186 DOI：

摘要

郑绍周教授认为，伏毒是一种复杂的致病因素，具有伏藏机体某处，复发缓解交替，导致病情复杂多变、缠绵难愈的特点，多发性硬化病情反复与之密切相关。基于此，郑教授提出伏毒伏于髓内是多发性硬化的核心病机，补肾和祛毒是治疗多发性硬化的两种基本治法。临床过程中，郑教授在辨证论治基础上，运用以补肾为本，并透邪解毒和涤痰化瘀法治疗多发性硬化，内补其虚以固本，外驱其伏毒以治标，通过逐步调节人体紊乱的免疫系统，使之恢复平衡，达到减少复发的目的。

Abstract

Professor Zheng Shaozhou believes that voltaic toxicity is a complex pathogenic factor, with relapse and remission alternately, resulting in complex and changeable disease, which is lingering and difficult to heal. The disease of multiple sclerosis is closely related to it. Based on this, Professor Zheng proposed that the Fu Du (hidden toxin) being in the medulla is the core pathogen of multiple sclerosis, and kidney tonic and detoxification are the two basic treatment methods for the treatment of multiple sclerosis. In the clinical practice, on the basis of dialectical treatment, Professor Zheng uses Kidney supplementation as the basis, and through the evil detoxification and sputum purification method to treat multiple sclerosis. By internal supplementation of its weakness the root (Zheng Qi) is consolidated, and by external driving of its voltaic poison to treat the symptoms. By gradually regulating the human body's disordered immune system, the balance of yin and Yang can be restored and the purpose of reducing its recurrence can be achieved.

关键词

多发性硬化伏毒补肾法祛毒法郑绍周

Keywords

multiple sclerosisFu DuKidney tonic methoddetoxification methodZheng Shaozhou

references

吴江. 神经病学[M]. 2版. 北京: 人民卫生出版社, 2010: 267.

WU J. Neurology[M]. 2nd ed. Beijing: People's Medical Publishing House, 2010: 267.

谢瑶. 多发性硬化复发与残疾的相关因素研究及“症-治-方”规律探析[D]. 北京: 北京中医药大学, 2019.

XIE Y. Research on the factors related to the recurrence of multiple sclerosis and disability and the analysis of the law of "symptomtreatment-prescription"[D]. Beijing: Beijing University of Chinese Medicine, 2019.

朴松兰, 马长春, 杨小存. 针刺干预多发性硬化研究现状[J]. 中国老年学杂志, 2020, 40(17): 3784-3787.

PIAO S L, MA C C, YANG X C. Research status of acupuncture intervention multiple sclerosis[J]. Chin J Gerontol, 2020, 40(17): 3784-3787.

李倩, 赵铎. 中西医结合治疗多发性硬化30例[J]. 中医研究, 2012, 25(1): 22-23.

LI Q, ZHAO D. Combination of traditional Chinese medicine and western medicine treated 30 cases of multiple sclerosis[J]. Tradit Chin Med Res, 2012, 25(1): 22-23.

周仲瑛. “伏毒”新识[J]. 世界中医药, 2007, 2(2): 73-75.

ZHOU Z Y. new knowledge of "Fu Du"[J]. World Chin Med, 2007, 2(2): 73-75.

陆韵薇, 于顾然. 以周仲瑛“伏毒”学说论治视神经脊髓炎谱系病[J]. 中医杂志, 2020, 61(11): 957-960.

LU Y W, YU G R. , Treatment of optic neuromyelitis spectrum disease with Zhou Zhongying's theory of "Fu Du"[J]. J Tradit Chin Med, 2020, 61(11): 957-960.

武继涛. 郑绍周教授从毒论治多发性硬化[J]. 光明中医, 2011, 26(10): 1973-1974.

WU J T. Professor Zheng Shaozhou treating multiple sclerosis from poison theory[J]. Guangming J Chin Med, 2011, 26(10): 1973-1974.

郭闫闫, 宫洪涛, 赵铎. 郑绍周教授从“内毒”论治多发性硬化的经验介绍[J]. 中国医药导报, 2021, 18(21): 134-137.

GUO Y Y, GONG H T, ZHAO D. Professor Zheng Shaozhou's experience in treating multiple sclerosis from"endotoxin"[J]. China Med Her, 2021, 18(21): 134-137.

赵铎, 王丹, 王猛川, 等. 郑绍周治疗多发性硬化组方用药规律分析[J]. 新中医, 2019, 51(4): 53-55.

ZHAO D, WANG D, WANG M C, et al. Analysis on administration laws of prescriptions of Zheng Shaozhou in treating multiple sclerosis[J]. J New Chin Med, 2019, 51(4): 53-55.

赖英哲, 王静滨, 尹建华, 等. 浅谈从“伏邪温病”理论辨治慢性乙型肝炎[J]. 中医药学报, 2018, 46(3): 71-74.

LAI Y Z, WANG J B, YIN J H, et al. Treatment and syndrome differentiation of chronic hepatitis B based on theory of "warm disease caused by incubating pathogens"[J]. Acta Chin Med Pharmacol, 2018, 46(3): 71-74.

谢阳, 刘梦兰, 罗思维, 等. 复发缓解型多发性硬化患者外周血miR-132、miR-146a与认知障碍的关系[J]. 中国免疫学杂志, 2021, 37(20): 2507-2510.

XIE Y, LIU M L, LUO S W, et al. Relationship between peripheral blood miR-146a and miR-132 and cognitive dysfunction in patients with relapse-remission multiple sclerosis[J]. Chin J Immunol, 2021, 37(20): 2507-2510.

何顺清, 彭永, 饶桂兰, 等. 基于中西医临床病证特点的多发性硬化动物模型分析[J]. 中国实验方剂学杂志, 2022, 28(4): 235-239.

HE S Q, PENG Y, RAO G L, et al. Animal model analysis of multiple sclerosis based on clinical characteristics of traditional Chinese and western medicine[J]. Chin J Exp Tradit Med Formulae, 2022, 28(4): 235-239.

LASSMANN H, BRADL M. Multiple sclerosis: experimental models and reality[J]. Acta Neuropathol, 2017, 133(2): 223-244.

OLSSON T, BARCELLOS L F, ALFREDSSON L. Interactions between genetic, lifestyle and environmental risk factors for multiple sclerosis[J]. Nat Rev Neurol, 2017, 13(1): 25-36.

李红岩, 侯振江, 刘建凤, 等. Th17/Treg细胞及其细胞因子在神经系统自身免疫性疾病中的研究进展[J]. 医学综述, 2021, 27(5): 889-895,900.

LI H Y, HOU Z J, LIU J F, et al. Research progress of Th17/treg cell and their cytokines in autoimmune diseases of nervous system[J]. Med Recapitul, 2021, 27(5): 889-895, 900.

武继涛. 郑绍周教授从毒论治多发性硬化经验[J]. 陕西中医, 2011, 32(8): 1036-1037.

WU J T. Professor Zheng Shaozhou's experience in treating multiple sclerosis from toxic theory[J]. Shaanxi J Tradit Chin Med, 2011, 32(8): 1036-1037.

邱伟, 徐雁. 多发性硬化诊断和治疗中国专家共识(2018版)[J]. 中国神经免疫学和神经病学杂志, 2018, 25(6): 387-394.

QIU W, XU Y. Chinese consensus on diagnosis and treatment on multiple slcerosis(2018 Version)[J]. Chin J Neuroimmunol Neurol, 2018, 25(6): 387-394.

蓝海, 周莲英. 刘友章用中西医结合疗法治疗多发性硬化经验[J]. 中医杂志, 2004, 45(7): 497.

LAN H, ZHOU L Y. Liu Youzhang's experience in treating multiple sclerosis with integrated traditional Chinese and Western medicine[J]. J Tradit Chin Med, 2004, 45(7): 497.

武继涛. 郑绍周教授肾虚理论治疗多发性硬化浅析[J]. 中医临床研究, 2014, 6(25): 44-45.

WU J T. An analysis of multiple sclerosis by the kidney deficiency theory of Zheng Shaozhou[J]. Clin J Chin Med, 2014, 6(25): 44-45.

王佳槚, 赵铎. 郑绍周治疗多发性硬化经验[J]. 辽宁中医杂志, 2019, 46(6): 1161-1163.

WANG J J, ZHAO D. Experience of Zheng Shaozhou on treatmenting multiple sclerosis[J]. Liaoning J Tradit Chin Med, 2019, 46(6): 1161-1163.

李亚娜, 兰瑞, 王燕, 等. 郑绍周分期治疗多发性硬化经验介绍[J]. 新中医, 2018, 50(7): 243-244.

LI Y N, LAN R, WANG Y, et al. Experience introduction of Zheng Shaozhou treating multiple sclerosis by stages[J]. J New Chin Med, 2018, 50(7): 243-244.

马运华, 武继涛, 徐云生. 多发性硬化的中医研究进展[J]. 中华中医药学刊, 2021, 39(2): 55-57.

MA Y H, WU J T, XU Y S. Traditional Chinese medicine research progress of multiple sclerosis[J]. Chin Arch Tradit Chin Med, 2021, 39(2): 55-57.

张高泽, 宫洪涛, 孔令霞. 郑绍周治疗多发性硬化经验[J]. 中医杂志, 2006, 47(10): 738.

ZHANG G Z, GONG H T, KONG L X. Zheng Shaozhou's experience in treating multiple sclerosis[J]. J Tradit Chin Med, 2006, 47(10): 738.

郭亚萌, 关亚超, 关运祥, 等. 从“湿热成痿”辨治多发性硬化[J]. 环球中医药, 2021, 14(3): 495-497.

GUO Y M, GUAN Y C, GUAN Y X, et al. Multiple sclerosis is identified from"Damp-Heat Leading to Wei Syndrome"[J]. Glob Tradit Chin Med, 2021, 14(3): 495-497.

樊永平, 王少卿. 论多发性硬化血瘀与活血化瘀治法[J]. 中华中医药杂志, 2018, 33(9): 3819-3821.

FAN Y P, WANG S Q. Discussion on activating blood and resolving stasis therapy in multiple sclerosis blood stasis[J]. China J Tradit Chin Med Pharm, 2018, 33(9): 3819-3821.

浏览量

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

郑绍周治疗多发性硬化经验

郑绍周治疗寻常型银屑病经验